For instance, miR-486 is downregulated in DN patients, and miR-486 from ADSC exosomes has been proven to protect podocytes against injury in vivo and in vitro by activating autophagy via the Smad1/mTOR signaling pathway [113]. This evidence concerns the gene MTOR and liver dysplastic nodule.